Advertisement Beacon Pharma licenses six products to Alliance - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Beacon Pharma licenses six products to Alliance

Beacon Pharmaceuticals has licensed UK marketing rights for six of its products to Alliance Pharmaceuticals for £2.4m;

So far, Alliance has acquired the rights to more than 50 pharmaceutical products.

The company distributes its products through wholesalers, retail pharmacies, hospitals and an international network of distributors.

Alliance Pharma chief executive John Dawson said they continue to evaluate further acquisition opportunities to complement their organic growth.